Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,275 | 1,402 | 1,417 | -867 | 1,971 |
| Accounts receivable | -263 | -9 | -21 | -14 | -26 |
| Other Working Capital | -1,852 | -2,900 | 3,239 | -474 | 4,439 |
| Other Operating Activity | -9,617 | -15,883 | -33,095 | -19,676 | -27,615 |
| Operating Cash Flow | $-10,456 | $-17,390 | $-28,460 | $-21,030 | $-21,230 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 59 | -44 | -858 | -1,149 | 263 |
| Sale Of Investment | N/A | 0 | 10,089 | 20,169 | 7,068 |
| Purchase Sale Intangibles | -223 | -289 | N/A | N/A | N/A |
| Investing Cash Flow | $-163 | $-334 | $9,231 | $19,020 | $7,331 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 10,692 | N/A | N/A | N/A |
| Debt Repayment | -15,416 | -509 | N/A | N/A | N/A |
| Common Stock Issued | 0 | 141 | 37,920 | 305 | 16,238 |
| Other Financing Activity | 5,805 | 0 | -1,888 | -1,577 | -977 |
| Financing Cash Flow | $-9,611 | $10,323 | $36,032 | $-1,272 | $15,261 |
| Exchange Rate Effect | 269 | 2,205 | -190 | -2 | -59 |
| Beginning Cash Position | 24,545 | 26,315 | 15,727 | 16,646 | 15,403 |
| End Cash Position | 4,583 | 21,118 | 32,339 | 13,361 | 16,706 |
| Net Cash Flow | $-20,231 | $-7,401 | $16,802 | $-3,282 | $1,361 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,456 | -17,390 | -28,460 | -21,030 | -21,230 |
| Capital Expenditure | -232 | -337 | -867 | -1,222 | -730 |
| Free Cash Flow | -10,689 | -17,727 | -29,327 | -22,252 | -21,961 |